<DOC>
	<DOCNO>NCT01460290</DOCNO>
	<brief_summary>Objectives : The investigator propose first-ever , prospective trial asenapine old adult bipolar disorder ( BD ) evaluate effect mood symptom , tolerability functional/general health status . Given dearth treatment data old adult BD , finding likely substantial clinical interest , may inform large future study assist refine bipolar treatment recommendation . Hypotheses : Primary : Asenapine therapy associate reduce bipolar manic depressive symptom old adult BD . Secondary : Asenapine therapy associate improved functional general health status , improve global psychopathology , good tolerability old adult BD .</brief_summary>
	<brief_title>Asenapine Treatment Older Adults With Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<criteria>Subjects must type I Bipolar disorder DSMIV criterion confirm Mini Neuropsychiatric Interview ( MINI ) Subjects must age 60 old Subjects must suboptimal response current psychotropic management include least one following : 1 . Behaviors symptoms irritability , agitation , mood lability diminish ability interact others place residence 2 . Diminished ability take care basic personal need place residence due symptom BD History intolerance resistance asenapine Clinical diagnosis dementia Minimental state ( MMSE ) &lt; 24 History TIA , stroke MI within past 12 month Medical illness clear , underlying etiology BD Unstable medical illness condition include prolonged QT interval , opinion study investigator , likely affect outcome study subject 's safety DSMIV substance dependence ( except nicotine caffeine ) within past 3 month . Rapid cycle BD define 4 discrete mood episode within previous 12 month . At high risk selfharm suicide</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>